Cargando…
Microbial metabolites and immune regulation: New targets for major depressive disorder
Treatments for depression and mood disorders have been singularly targeted at the brain without consideration for the context of the rest of the body. As evidence mounts for a role of autoimmunity and inflammation as risk factors and contributors to mood disorders, attention has shifted to one of th...
Autores principales: | Merchak, Andrea, Gaultier, Alban |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474524/ https://www.ncbi.nlm.nih.gov/pubmed/34589904 http://dx.doi.org/10.1016/j.bbih.2020.100169 |
Ejemplares similares
-
Regulation of Allergic Immune Responses by Microbial Metabolites
por: Park, Hyun Jung, et al.
Publicado: (2018) -
Regulation of common neurological disorders by gut microbial metabolites
por: Park, Jeongho, et al.
Publicado: (2021) -
The Role of Gut Mucins in the Etiology of Depression
por: Rivet-Noor, Courtney, et al.
Publicado: (2020) -
Evidence for oligodendrocyte progenitor cell heterogeneity in the adult mouse brain
por: Beiter, Rebecca M., et al.
Publicado: (2022) -
Inflammatory Process and Immune System in Major Depressive Disorder
por: Ruiz, Norma Angélica Labra, et al.
Publicado: (2021)